Skip to content

The Journal for ImmunoTherapy of Cancer

Just another bmjjournals-chicken.bmj.com Managed WordPress Site Sites site

Efficient preclinical treatment of cortical T cell acute lymphoblastic leukemia with T lymphocytes secreting anti-CD1a T cell engagers

Post navigation

Previous post

Long-term outcomes with nivolumab plus ipilimumab versus sunitinib in first-line treatment of patients with advanced sarcomatoid renal cell carcinoma

Search

Recent Posts

Robots

Recent Comments

No comments to show.

Archives

September 2022

Categories

Uncategorized

The Journal for ImmunoTherapy of Cancer

Proudly powered by WordPress.